Last update July 15, 2022
Very Low Risk
Used as systemic treatment of onchocercosis, strongyloidiasis, filariasis and scabies (Pérez 2009, Prescrire 2002). Oral administration. Topically it is used in the treatment of pediculosis capitis. Used experimentally in the treatment of the COVID-19 coronavirus. (Vallejos 2020)
Its pharmacokinetic data (high molecular weight and high protein binding) explain the small excretion in breast milk, without clinical relevance for the infant. (Rodari 2020, Ogbuokiri 1993)
No problems have been observed in infants whose mothers were taking it. (Porto 2003, Ogbuokiri 1994 y 1993)
Expert authors consider the use of this medication safe during breastfeeding. (Anderson 2020)
American Academy of Pediatrics: Maternal Medication Usually Compatible With Breastfeeding. (Butler 2014, AAP 2001)
We do not have alternatives for C48 H74 O14 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM